Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2005
11/24/2005WO2005111024A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111023A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111019A1 Novel pyridazinone derivatives as inhibitors of cdk2
11/24/2005WO2005111018A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
11/24/2005WO2005111017A1 Triazine compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005111016A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111015A1 Substituted pyrrolidine derivative
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005110998A1 Scalable synthesis of imidazole derivatives
11/24/2005WO2005110994A2 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110991A1 1-aryl-4-substituted isoquinolines
11/24/2005WO2005110989A1 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
11/24/2005WO2005110988A1 Pyridone compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005110987A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005WO2005110986A1 Hydroformylation process for pharmaceutical intermediate
11/24/2005WO2005110983A1 Azetidine glycine transporter inhibitors
11/24/2005WO2005110416A2 4,5-disubstituted-2-aryl pyrimidines
11/24/2005WO2005110408A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
11/24/2005WO2005109987A2 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
11/24/2005WO2005085198A3 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005WO2005080403A3 Chemical process
11/24/2005WO2005046604A3 Heteroaryl-hydrazone compounds
11/24/2005WO2005041875A3 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
11/24/2005WO2004113297A9 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/24/2005US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261401 for stabilizing aqueous polymer systems (water borne coatings, aqueous inks, aqueous ink jet media, and photocured aqueous systems) against oxidative, thermal and actinic radiation
11/24/2005US20050261353 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
11/24/2005US20050261346 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261334 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
11/24/2005US20050261325 Gamma-aminoamide modulators of chemokine receptor activity
11/24/2005US20050261322 HIV integrase inhibitors
11/24/2005US20050261319 Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261310 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/24/2005US20050261309 Imidazole compounds
11/24/2005US20050261308 1-(2-Chloro-6-piperazin-1-yl-pyrimidin-4-ylmethyl)-3,4-dihydro-1H-quinolin-2-one; substituted benzoxazinone compounds; 5-HT6 modulators/antagonists; Parkinson's disease, Huntington's disease, manic depression, psychoses, Alzheimer's disease and memory disorders
11/24/2005US20050261299 e.g. 4-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1(3)H-imidazol-2-yl)methyl)benzamide; transforming growth factor- beta (TGF- beta ) type I receptor (ALK5) and/or the activin type I receptor (ALK4) antagonist; wound healing agent, antidiabetic, anticarcinogenic, antiinflmmatory agent
11/24/2005US20050261296 Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
11/24/2005US20050261295 Pyrimidine as PLK inhibitors
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
11/24/2005US20050261283 Methods and compositions for the treatment of graft failure
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261268 For therapy of allergic disorders, proliferative disorders, autoimmune disorders, conditions associated with organ transplant, inflammatory disorders, immunologically mediated disorders, viral diseases, or destructive bone disorders
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050261176 Compositions and methods relating to novel compounds and targets thereof
11/24/2005DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments
11/24/2005CA2567154A1 Novel pyridazinone derivatives as inhibitors of cdk2
11/24/2005CA2566707A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2566477A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2565953A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005CA2565514A1 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2565211A1 Amino-tetrazoles analogues and methods of use
11/24/2005CA2564952A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005CA2564517A1 1-aryl-4-substituted isoquinolines
11/24/2005CA2564501A1 Azetidine glycine transporter inhibitors
11/24/2005CA2564325A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005CA2564199A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2563607A1 4,5-disubstituted-2-aryl pyrimidines
11/24/2005CA2562715A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
11/24/2005CA2508065A1 Antiproliferative drug and delivery device
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1598348A1 Novel pyridazinone derivatives as inhibitors of CDK2
11/23/2005EP1598347A1 Polymorphs of pantoprazole sodium salt and process for the preparation thereof
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598343A1 2-Arylaminopyrimidine derivatives as PLK inhibitors
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597254A1 Indole-derivative modulators of steroid hormone nuclear receptors
11/23/2005EP1597252A1 Pyridine derivatives as fungicidal compounds
11/23/2005EP1597250A2 Indolylmaleimide derivatives
11/23/2005EP1597249A1 Anthelmintic agents and insecticidal compositions
11/23/2005EP1597244A1 Ethynyl derivatives serving as factor xa inhibitors
11/23/2005EP1597235A1 Non-nucleoside reverse transcriptase inhibitors
11/23/2005EP1597231A1 Derivatives of azasugars as anticancer agents
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
11/23/2005EP1596656A2 Pyrazoles and methods of making and using the same
11/23/2005EP1503754B1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP0934263B1 Non-immunosuppressant fkbp rotamase inhibitors
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005CN1701071A Therapeutic agents useful for treating pain
11/23/2005CN1701070A Delta1-pyrrolines compound
11/23/2005CN1701069A 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
11/23/2005CN1701068A Novel compounds and their use
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/23/2005CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 1080